1Tipples GA, Ma MM, Fischer KP, et al. Mutation in HBV RNA - dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology, 1996, 24 (3): 714.
2Buti M, Jardi R, Cotrina M, et al. Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine. J Hepatol, 1998, 28 (3): 510.
3Marzano A, Debernardi - Venon W, Condreay L, et al.Efficacy of lamivudine re- treatment in a patient with hepatitis B virus (HBV) recurrence after liver transplantation and HBV - DNA breakthrough during the first treatment.Transplantation, 1998, 65 (11): 1499.
4Chayama K, Suzuki Y, Kobayashi M, et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during long - term lamivudine therapy and re - takeover by wild type after cessation of therapy. Hepatology, 1998, 27(6): 1711.
5Tassopoulos NC, Volpes R, Pastore G, et al. Efficacy of lamivudine in patients with hepatitis B e antigen - negative/hepatitis B virus DNA- positive (precore mutant) chronic hepatitis B. Hepatology, 1999, 29 (3): 889.
6Bartholomew MM, Jansen RW, Jeffers LJ, et al. Hepatitis- B- virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet,1997, 349 (9044): 20.
7Allen MI, Deslauriers M, Andrews CW, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology, 1998, 27 (6): 1670.
8Ladner SK, Miller TJ, King RW. The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2' - deoxy - 3' - thiacytidine and a reduced ability to synthesize viral DNA. Antimicrob Agents Chemother,1998, 42 (8):2128.
9Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology, 1998, 27 (2): 628.
10Seigneres B, Aguesse - Germon S, Pichoud C, et al.Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo. J Hepatol, 2001, 34 ( 1 ):114
1Bartholomew MM, Jansen P.W, Jeffers LJ, et al.Hepattis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J] . Lancet, 1997, 349 (9044): 20.
2Allen MI, Deslauriers M, Andrews CW, et al.Identification and characterization of mutations in hepatitis B virus resistant to lamivudine [J]Hepatology, 1998, 27 (6): 1670.
3Ladner SK, Miller TJ, King RW. The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2'-deoxy-3'-thiacytidine and a reduced ability to synthesize viral DNA [J]Anfimicrob Agents Chemother, 1998,42 (8): 2128.
4Melegari M, Scaglioni PP, Wands JR. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective [J] .Hepatology, 1998, 27 (2): 628.
